Vialase has a total of 104 patents globally, out of which 54 have been granted. Of these 104 patents, more than 78% patents are active. United States of America is where Vialase has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Vialase.
Vialase founded in 2019, Vialase is an ophthalmic medical technology company developing noninvasive, image-guided femtosecond laser treatments for glaucoma. Leveraging deep expertise in laser-based eye surgery, the company aims to improve patient outcomes, with products currently awaiting regulatory approval.
Do read about some of the most popular patents of Vialase which have been covered by us in this article and also you can find Vialase patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vialase patent portfolio.
How many patents does Vialase have?
Vialase has a total of 104 patents globally. These patents belong to 15 unique patent families. Out of 104 patents, 82 patents are active.
How Many Patents did Vialase File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Vialase Applications Filed | Vialase Patents Granted |
| 2026 | – | 5 |
| 2025 | 1 | 11 |
| 2024 | 3 | 13 |
| 2023 | 13 | 15 |
| 2022 | 11 | 4 |
| 2021 | 23 | 4 |
| 2020 | 17 | 2 |
| 2019 | 32 | – |
| 2018 | 4 | – |
How many Vialase patents are Alive/Dead?
Worldwide Patents
How Many Patents did Vialase File in Different Countries?
Countries in which Vialase Filed Patents
| Country | Patents |
| United States of America | 32 |
| Europe (EPO) | 16 |
| Canada | 8 |
| Australia | 8 |
| Brazil | 7 |
| Germany | 4 |
| Spain | 4 |
| Hungary | 4 |
| Austria | 3 |
Where are Research Centres of Vialase Patents Located?
The Research Centre for all the Vialase patents is the United States of America.
10 Best Vialase Patents
US10821023B2 is the most popular patent in the Vialase portfolio. It has received 24 citations so far from companies like Femto Vox Inc and Eyeflow Inc.
Below is the list of 10 most cited patents of Vialase:
| Publication Number | Citation Count |
| US10821023B2 | 24 |
| US10821024B2 | 21 |
| WO2020018242A1 | 19 |
| US11173067B2 | 14 |
| US11246754B2 | 13 |
| US11110006B2 | 12 |
| US20210307964A1 | 12 |
| US11583445B2 | 6 |
| US11564567B2 | 6 |
| US11612315B2 | 5 |
What Percentage of Vialase US Patent Applications were Granted?
Vialase (Excluding its subsidiaries) has filed 30 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 15 have been granted leading to a grant rate of 88.24%.
Below are the key stats of Vialase patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Vialase?
| Law Firm | Total Applications | Success Rate |
| Loza & Loza Llp | 30 | 88.24% |
What are Vialase key innovation segments?
What Technologies are Covered by Vialase?
The chart below distributes patents filed by Vialase in different countries on the basis of the technology protected in patents. It also represents the markets where Vialase thinks it’s important to protect particular technological inventions.
R&D Focus: How has Vialase search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Vialase?
